Brookdale Senior Living Inc. BKD ← Back to all reports

Brookdale Senior Living Inc.

BKD · Healthcare
A ★★★★ Buy
Aug 21, 2026 · Score 88 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $11.81
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $11.00 ($10.50–$11.50)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $17.65
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+49.4%

Type A - Brookdale Senior Living Inc. (BKD) 20260821 Stock Analysis

📅 Brookdale Key Upcoming Events

🏢 Step 1: Brookdale Company Overview & Business Model

Q1-A1. What is Brookdale?

Q1-A2. How Does Brookdale Make Money?

Q1-A3. Brookdale’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Brookdale’s Competitors?

Q1-A5. Brookdale Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Brookdale’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Brookdale Have a Durable Economic Moat?

Q2-A2. Is Brookdale’s Growth Sustainable?

Q2-A3. How Does Brookdale Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Brookdale Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Brookdale? (Margins & ROIC)

Q3-A3. What Drives Brookdale’s Returns? (ROIC Breakdown)

Q3-A4. Are Brookdale’s Earnings High Quality?

Q3-A5. Is Brookdale’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Brookdale Forensic Accounting & Dilution Review

Q4-A1. Does Brookdale Have Accounting Red Flags?

Q4-A2. Is Brookdale Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Brookdale’s Cash Flow?

Q4-A4. Is Brookdale Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Brookdale Management & Shareholder Alignment

Q5-A1. Can You Trust Brookdale’s Management? (Guidance Track Record)

Q5-A2. What Are Brookdale Insiders Doing?

Q5-A3. Is Brookdale’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Brookdale Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Brookdale Guidance

Q6-A2. What Is Brookdale’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Brookdale Catalysts & Price Triggers

Q7-A1. What Could Move Brookdale Stock? (Top 3 Catalysts)

Q7-A2. Brookdale’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Brookdale Fairly Valued? Valuation Analysis

Q8-A1. Brookdale’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Brookdale vs Peers: Valuation Comparison

Q8-A3. Is Brookdale Cheap or Expensive vs Its History?

Q8-A4-1. What Growth Hurdle Does the Market Demand From Brookdale? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Brookdale’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Brookdale? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Brookdale?

Q9-A2. How Sensitive Is Brookdale to the Economy?

Q9-A3. Brookdale Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Brookdale Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Brookdale? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Brookdale’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Brookdale’s Heavy Debt Load Its Biggest Weakness?

Q2: Can Brookdale’s 14x EV/EBITDA Be Justified by the Demographic Supercycle?

Q3: How Will the Transition to Nikolas Stengle as CEO Impact Operations?

Q4: Will Brookdale’s 17-Community Portfolio Acquisition Drive Meaningful Free Cash Flow?

Q5: Can Brookdale Sustain Its Recent Return to Profitability Despite Rising Labor Costs?

Q6: How Does Brookdale’s Shift Toward Owned Real Estate Alter Its Risk Profile?

Q7: Are the Recent Medicare and Medicaid Policy Shifts a Tailwind or Headwind for Brookdale?

Q8: What Impact Do Higher Interest Rates Have on Brookdale’s Refinancing Capabilities?

Q9: How Vulnerable Is Brookdale’s Assisted Living Segment to Local Market Oversupply?

Q10: Does Brookdale HealthPlus Provide a Meaningful Competitive Advantage Over Peers?